Georgia vs Montenegro: HIV-positive TB patients on ART (antiretroviral therapy)
Georgia
100.0%
in 2024
Montenegro
100.0%
in 2023
Georgia rank
1st
Montenegro rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Georgia
- Montenegro
How they compare
Georgia currently reports 100.0% against 100.0% in Montenegro, a difference of 0.0%.
The two have swapped places 2 times across 6 shared years of data; in 2006 it was Montenegro ahead.
Georgia ranks 1st and Montenegro ranks 1st of 144 countries.
Across the 3 decades both report, Georgia averaged higher in 1 and Montenegro in 2.
Head to head by decade
| Decade | Georgia | Montenegro | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 53.0% | 100.0% | 47.0% | Montenegro |
| 2010s | 84.0% | 100.0% | 16.0% | Montenegro |
| 2020s | 91.5% | 75.0% | 16.5% | Georgia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Georgia or Montenegro?
- Georgia, at 100.0% against 100.0% in Montenegro as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Georgia and Montenegro?
- 0.0%, with Georgia ahead.
- How many years of comparable data are there for Georgia and Montenegro?
- 6 years are reported by both, from 2006 to 2023.
- How do Georgia and Montenegro rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Georgia ranks 1st and Montenegro ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.